Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Korosho Proposes to Raise Monthly Upper Limit of Copayments
October 22, 2001
- WORLD NEWS IN BRIEF
October 22, 2001
- 10 New Themes for Basic Research Promotion Selected
October 22, 2001
- NEW PRODUCTS NEWS IN BRIEF
October 22, 2001
- REGULATORY NEWS IN BRIEF
October 22, 2001
- Abbereviationon of the week
October 22, 2001
- Not to Expect Gov't to Adopt ATP Soon: Mr Butler of PhRMA -1-
October 22, 2001
- Benefits of INNOVA2000 Explained: GE Yokogawa Seminar
October 22, 2001
- Not to Expect Gov't to Adopt ATP Soon: Mr Butler of PhRMA -2-
October 22, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 22, 2001
- Mitsubishi Pharma Establishes Subsidiaries in US, UK
October 22, 2001
- Industry Expresses Opinions on Pricing of Medical Devices: Chuikyo
October 22, 2001
- Kaken Downwardly Revises Business Forecasts for FY2001
October 15, 2001
- 36 New Products Receive Regulatory Approval
October 15, 2001
- NEW PRODUCTS NEWS IN BRIEF
October 15, 2001
- Use of Domestic Cow-Derived Raw Materials in Drugs Banned
October 15, 2001
- OTC NEWS IN BRIEF
October 15, 2001
- Switch to Materials from BSE-free Countries Considered by Makers
October 15, 2001
- Cooperation of Medical Institutions Essential for Immediate PMS
October 15, 2001
- Medical Professionals Asked For Cooperation with Immediate PMS
October 15, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…